Application of Immunohistochemistry in Clinical Practices as a Standardized Assay for Breast Cancer
-
- Masuda Shinobu
- Division of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine
-
- Nakanishi Yoko
- Division of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine
抄録
<p>Immunohistochemistry (IHC) has become an indispensable tool in the clinical practices for breast cancer; however, to achieve its standardization, numerous issues need to be overcome. In this review, we describe the development of IHC as an important clinical tool, and the challenges in standardizing IHC results for patients. We also present ideas for resolving the remaining issues and unmet needs, along with future directions.</p>
収録刊行物
-
- Ａｃｔａ Ｈｉｓｔｏｃｈｅｍｉｃａ ｅｔ Ｃｙｔｏｃｈｅｍｉｃａ
-
Ａｃｔａ Ｈｉｓｔｏｃｈｅｍｉｃａ ｅｔ Ｃｙｔｏｃｈｅｍｉｃａ 56 (1), 1-8, 2023-02-28
日本組織細胞化学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390858209198076544
-
- ISSN
- 13475800
- 00445991
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
-
- 抄録ライセンスフラグ
- 使用不可